The use of embolic protection devices (EPDs) when treating coronary saphenous vein bypass grafts, performing carotid arterial stenting and treating acute coronary syndromes is well accepted.Load more
The use of embolic protection devices (EPDs) when treating coronary saphenous vein bypass grafts, performing carotid arterial stenting and treating acute coronary syndromes is well accepted.
Embolic protection devices capture arteriosclerotic debris that is released during angioplasty and stenting. There is no doubt that these devices are an important part of the procedure. There is some evidence that use of embolic protection devices during carotid and saphenous vein graft interventions significantly reduces the peri-procedural complication rates.
Reports of single-centre clinical series performed in native coronary arteries and renal arteries suggest that the use of embolic protection may increase the safety of these procedures. However, due to the low complication rates of these interventions without the use of embolic protection devices, large randomised trials are needed to statistically prove the clinical efficacy of these devices.Load Less
Michael Teitelbaum, Rafail Kotronias, Luciano A Sposato, et alInterventional Cardiology Review 2019;14(1):22–5DOI: https://doi.org/10.15420/icr.2018.32.2
Safety and Efficacy of Protected Cardiac Intervention: Clinical Evidence for Sentinel Cerebral Embolic ProtectionUlrich SchäferInterventional Cardiology Review 2017;12(2):128–32.DOI: https://doi.org/10.15420/icr.2017:19:2
Need for Embolic Protection During Transcatheter Aortic Valve Implantation: An Interventionalist’s Perspective on Histopathology FindingsHerbert G Kroon, Nicolas MDA Van MieghemInterventional Cardiology Review 2017;12(1):36–9DOI: https://doi.org/10.15420/icr.2016:30:2
Martin G RadvanyInterventional Cardiology Review 2017;12(1):31–5DOI: https://doi.org/10.15420/icr.2016:23:2